跳至主要内容
临床试验/NCT01079910
NCT01079910撤回1 期

Clinical Efficacy of an Experimental Toothpaste

GlaxoSmithKline0 个研究点开始时间: 2009年12月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
撤回
主要终点
Change from baseline Bleeding Index at 24 weeks

研究概览

简要总结

The objective of this study is to evaluate the effect of an experimental toothpaste on maintaining gingival health over a 24 week period measured through modified gingival index, bleeding, plaque, and plaque bacteria. Prior to commencing study treatment, subjects will undergo a dental prophylaxis followed by a 2 week period of oral hygiene instruction and weekly professional tooth cleaning to bring the subjects to their optimum gingival health prior to commencing study treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy subjects aged 18 years and older
  • A minimum of 20 permanent gradable teeth
  • For baseline eligibility, subjects must have a minimum Modified Gingival Index score of 1.5-2.3.

排除标准

  • 未提供

研究组 & 干预措施

Experimental toothpaste

Experimental

0.1% isopropylmethylphenol and 1150ppm fluoride

干预措施: isopropylmethylphenol and Fluoride (Drug)

Marketed toothpaste

Other

NaF/Silica toothpaste containing 1150ppm fluoride

干预措施: Fluoride and Silica (Drug)

结局指标

主要结局

Change from baseline Bleeding Index at 24 weeks

时间窗: baseline to 24 weeks

Change from baseline Modified Gingival Index at 24 weeks

时间窗: baseline to 24 weeks

次要结局

  • Change from baseline Modified Gingival Index at weeks 6 & 12(baseline to week 12)
  • Change from baseline Bleeding Index at weeks 6 & 12(baseline to week 12)
  • Change from baseline Plaque Index at weeks 6, 12 & 24(baseline to week 24)
  • Change from baseline plaque bacteria at weeks 12 & 24(baseline to week 24)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验